Table 1.
Baseline characterictics of treatment group
| Characteristics | UC-MSC | Total (n) | P value | |
|---|---|---|---|---|
| Intubated (n = 99) | Unintubated (n = 111) | |||
| Sex, n (%) | 210 | 0,64a | ||
| Male | 74 (74.7%) | 79 (71.2%) | 153 | |
| Female | 25 (25.3%) | 32(28.8%) | 57 | |
| Age, mean ± SD, years | 61.22 ± 11.77 | 57.36 ± 12.00 | 0,02b | |
| Age range, years | 27–83 | 23–81 | ||
| Weight, mean ± SD, kg | 90.63 ± 12.86 | 83.86 ± 11.66 | < 0,001b | |
In this study, patients who were intubated were in the critical disease category, while patients who were not intubated were in the severe disease category. COVID-19 disease severity; Mild, moderate, severe and critically disease. Severe Illness: Individuals who have SpO2 < 94% on room air at sea level, a ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) < 300 mm Hg, respiratory frequency > 30 breaths/min, or lung infiltrates > 50%. Critical Illness: Individuals who have respiratory failure, septic shock, and/or multiple organ dysfunction (3)
Abbreviations: UC-MSC umbilicial cord mesenchymal stem cell, n number of samples
a Pearson Chi-square test
b t-test